4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-023203
President, R&D sold 18,000 shares at $30.32 ($545,760)
- President, R&D acquired 18,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bergstrom Donald A · President, R&D
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-01 | Exercise or conversion : show line 1 in the form | +18,000 | $4.12 | $74,160 | 112,304 | D |
| 2022-04-01 | Sale : show line 2 in the form | −18,000 | $30.32 | $545,760 | 94,304 | D |
| Open-market sales · 18,000 sh · avg $30.32 · $545,760 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-01 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −18,000 | 199,456 | D |
Loading xslF345X03/doc4.xml…